annual CFO:
-$69.10M-$44.16M(-177.05%)Summary
- As of today (July 11, 2025), SLNO annual cash flow from operations is -$69.10 million, with the most recent change of -$44.16 million (-177.05%) on December 31, 2024.
- During the last 3 years, SLNO annual CFO has fallen by -$41.33 million (-148.82%).
- SLNO annual CFO is now -7705.69% below its all-time high of -$885.20 thousand, reached on December 31, 2013.
Performance
SLNO Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$32.75M-$8.76M(-36.52%)Summary
- As of today (July 11, 2025), SLNO quarterly cash flow from operations is -$32.75 million, with the most recent change of -$8.76 million (-36.52%) on March 31, 2025.
- Over the past year, SLNO quarterly CFO has dropped by -$20.22 million (-161.43%).
- SLNO quarterly CFO is now -1670.91% below its all-time high of $2.08 million, reached on March 31, 2013.
Performance
SLNO quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$89.32M-$20.22M(-29.27%)Summary
- As of today (July 11, 2025), SLNO TTM cash flow from operations is -$89.32 million, with the most recent change of -$20.22 million (-29.27%) on March 31, 2025.
- Over the past year, SLNO TTM CFO has dropped by -$58.58 million (-190.57%).
- SLNO TTM CFO is now -4384.14% below its all-time high of $2.08 million, reached on March 31, 2013.
Performance
SLNO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SLNO Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -177.1% | -161.4% | -190.6% |
| 3 y3 years | -148.8% | -414.8% | -235.2% |
| 5 y5 years | -297.7% | -478.8% | -306.2% |
SLNO Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -232.5% | at low | -608.9% | at low | -329.8% | at low |
| 5 y | 5-year | -297.7% | at low | -608.9% | at low | -329.8% | at low |
| alltime | all time | -7705.7% | at low | -1670.9% | at low | -4384.1% | at low |
SLNO Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$32.75M(+36.5%) | -$89.32M(+29.3%) |
| Dec 2024 | -$69.10M(+177.0%) | -$23.99M(+60.7%) | -$69.10M(+34.4%) |
| Sep 2024 | - | -$14.93M(-15.4%) | -$51.42M(+20.1%) |
| Jun 2024 | - | -$17.65M(+40.9%) | -$42.83M(+39.3%) |
| Mar 2024 | - | -$12.53M(+98.4%) | -$30.74M(+23.3%) |
| Dec 2023 | -$24.94M(+20.0%) | -$6.31M(-0.3%) | -$24.94M(+4.9%) |
| Sep 2023 | - | -$6.33M(+13.8%) | -$23.77M(+7.6%) |
| Jun 2023 | - | -$5.57M(-17.3%) | -$22.09M(+4.5%) |
| Mar 2023 | - | -$6.73M(+30.8%) | -$21.15M(+1.8%) |
| Dec 2022 | -$20.78M(-25.2%) | -$5.14M(+10.5%) | -$20.78M(-7.6%) |
| Sep 2022 | - | -$4.66M(+0.8%) | -$22.50M(-3.2%) |
| Jun 2022 | - | -$4.62M(-27.4%) | -$23.25M(-12.7%) |
| Mar 2022 | - | -$6.36M(-7.3%) | -$26.64M(-4.1%) |
| Dec 2021 | -$27.77M(+10.1%) | -$6.86M(+27.0%) | -$27.77M(-0.0%) |
| Sep 2021 | - | -$5.41M(-32.5%) | -$27.77M(-2.7%) |
| Jun 2021 | - | -$8.01M(+7.0%) | -$28.53M(+5.5%) |
| Mar 2021 | - | -$7.49M(+9.0%) | -$27.05M(+7.3%) |
| Dec 2020 | -$25.22M(+45.2%) | -$6.87M(+11.4%) | -$25.22M(+7.6%) |
| Sep 2020 | - | -$6.16M(-5.7%) | -$23.43M(+6.6%) |
| Jun 2020 | - | -$6.53M(+15.5%) | -$21.99M(+13.7%) |
| Mar 2020 | - | -$5.66M(+11.5%) | -$19.35M(+11.3%) |
| Dec 2019 | -$17.38M(+48.7%) | -$5.08M(+7.6%) | -$17.38M(+8.4%) |
| Sep 2019 | - | -$4.72M(+21.2%) | -$16.04M(+14.6%) |
| Jun 2019 | - | -$3.89M(+5.6%) | -$13.99M(+8.9%) |
| Mar 2019 | - | -$3.69M(-1.3%) | -$12.85M(+10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$11.68M(+17.4%) | -$3.74M(+39.6%) | -$11.68M(+9.4%) |
| Sep 2018 | - | -$2.68M(-2.7%) | -$10.68M(+6.3%) |
| Jun 2018 | - | -$2.75M(+9.1%) | -$10.04M(-2.4%) |
| Mar 2018 | - | -$2.52M(-7.8%) | -$10.29M(+3.4%) |
| Dec 2017 | -$9.95M(-26.3%) | -$2.73M(+33.7%) | -$9.95M(+0.4%) |
| Sep 2017 | - | -$2.04M(-31.7%) | -$9.91M(-7.0%) |
| Jun 2017 | - | -$2.99M(+37.1%) | -$10.65M(-9.0%) |
| Mar 2017 | - | -$2.18M(-18.8%) | -$11.70M(-13.3%) |
| Dec 2016 | -$13.50M(+31.1%) | -$2.69M(-3.5%) | -$13.50M(-4.9%) |
| Sep 2016 | - | -$2.79M(-31.0%) | -$14.19M(-0.5%) |
| Jun 2016 | - | -$4.04M(+1.4%) | -$14.26M(+14.3%) |
| Mar 2016 | - | -$3.98M(+17.9%) | -$12.47M(+21.1%) |
| Dec 2015 | -$10.30M(+129.7%) | -$3.38M(+18.1%) | -$10.30M(+21.5%) |
| Sep 2015 | - | -$2.86M(+27.1%) | -$8.48M(+23.2%) |
| Jun 2015 | - | -$2.25M(+24.4%) | -$6.88M(+18.9%) |
| Mar 2015 | - | -$1.81M(+16.2%) | -$5.78M(+29.0%) |
| Dec 2014 | -$4.48M(+406.6%) | -$1.56M(+23.3%) | -$4.48M(+22.9%) |
| Sep 2014 | - | -$1.26M(+9.1%) | -$3.65M(+10.2%) |
| Jun 2014 | - | -$1.16M(+127.3%) | -$3.31M(-4.8%) |
| Mar 2014 | - | -$509.00K(-29.5%) | -$3.48M(+293.0%) |
| Dec 2013 | -$885.20K(-74.7%) | -$722.20K(-21.8%) | -$885.20K(+443.1%) |
| Sep 2013 | - | -$924.10K(-30.2%) | -$163.00K(-121.4%) |
| Jun 2013 | - | -$1.32M(-163.5%) | $761.10K(-63.5%) |
| Mar 2013 | - | $2.08M | $2.08M |
| Dec 2012 | -$3.50M | - | - |
FAQ
- What is Soleno Therapeutics, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. annual CFO year-on-year change?
- What is Soleno Therapeutics, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. quarterly CFO year-on-year change?
- What is Soleno Therapeutics, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Soleno Therapeutics, Inc.?
- What is Soleno Therapeutics, Inc. TTM CFO year-on-year change?
What is Soleno Therapeutics, Inc. annual cash flow from operations?
The current annual CFO of SLNO is -$69.10M
What is the all time high annual CFO for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high annual cash flow from operations is -$885.20K
What is Soleno Therapeutics, Inc. annual CFO year-on-year change?
Over the past year, SLNO annual cash flow from operations has changed by -$44.16M (-177.05%)
What is Soleno Therapeutics, Inc. quarterly cash flow from operations?
The current quarterly CFO of SLNO is -$32.75M
What is the all time high quarterly CFO for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high quarterly cash flow from operations is $2.08M
What is Soleno Therapeutics, Inc. quarterly CFO year-on-year change?
Over the past year, SLNO quarterly cash flow from operations has changed by -$20.22M (-161.43%)
What is Soleno Therapeutics, Inc. TTM cash flow from operations?
The current TTM CFO of SLNO is -$89.32M
What is the all time high TTM CFO for Soleno Therapeutics, Inc.?
Soleno Therapeutics, Inc. all-time high TTM cash flow from operations is $2.08M
What is Soleno Therapeutics, Inc. TTM CFO year-on-year change?
Over the past year, SLNO TTM cash flow from operations has changed by -$58.58M (-190.57%)